Enhancement of the mutagenicities of N-methyl-N'-nitro-N-nitrosoguanidine and N-methyl-N-nitrosourea by glucose. 1980

A Shirai, and K Umezawa, and T Matsushima, and T Sugimura

The mutagenicity of N-methyl-N'-nitro-N-nitrosoguanidine to Salmonella typhimurium hisG46 was enhanced by pre-incubating the chemical with bacteria in sodium phosphate buffer. Addition of glucose (to 15 mM) to the pre-incubation mixture further enhanced the mutagenicity. Pre-incubation with glucose also increased the mutagenicity of N-methyl-N-nitrosourea. Fructose, galactose, pyruvate and succinate also enhanced the mutagenicity of N-methyl-N'-nitro-N-nitrosoguanidine. The effect of glucose was observed with S. typhimurium strains hisG46, TA1975, TA1950, TA1535 and TA100.

UI MeSH Term Description Entries
D008769 Methylnitronitrosoguanidine A nitrosoguanidine derivative with potent mutagenic and carcinogenic properties. Methylnitrosonitroguanidine,Nitrosomethylnitroguanidine,Nitrosonitromethylguanidine,MNNG,N-Methyl-N'-nitro-N-nitrosoguanidine,N Methyl N' nitro N nitrosoguanidine
D008770 Methylnitrosourea A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosomethylurea,N-Methyl-N-nitrosourea,NSC-23909,N Methyl N nitrosourea,NSC 23909,NSC23909
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.
D012486 Salmonella typhimurium A serotype of Salmonella enterica that is a frequent agent of Salmonella gastroenteritis in humans. It also causes PARATYPHOID FEVER. Salmonella typhimurium LT2

Related Publications

A Shirai, and K Umezawa, and T Matsushima, and T Sugimura
January 1988, Voprosy onkologii,
A Shirai, and K Umezawa, and T Matsushima, and T Sugimura
January 2004, Report on carcinogens : carcinogen profiles,
A Shirai, and K Umezawa, and T Matsushima, and T Sugimura
January 2002, Report on carcinogens : carcinogen profiles,
A Shirai, and K Umezawa, and T Matsushima, and T Sugimura
April 1974, Mutation research,
A Shirai, and K Umezawa, and T Matsushima, and T Sugimura
September 1974, Mutation research,
A Shirai, and K Umezawa, and T Matsushima, and T Sugimura
February 1966, Canadian journal of microbiology,
A Shirai, and K Umezawa, and T Matsushima, and T Sugimura
July 1991, International journal of cancer,
A Shirai, and K Umezawa, and T Matsushima, and T Sugimura
December 1987, Mutation research,
A Shirai, and K Umezawa, and T Matsushima, and T Sugimura
November 1973, Cancer research,
A Shirai, and K Umezawa, and T Matsushima, and T Sugimura
September 1993, British journal of cancer,
Copied contents to your clipboard!